ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,238Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 2588

$861K Total Retail Price of All Prescriptions

Rank: 128 out of 2588

439 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 439 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

15% of this provider’s 439 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 12,857 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
FUROSEMIDE 669 643 1 5
LEVOTHYROXINE SODIUM 567 509 2 2
POTASSIUM CHLORIDE 493 467 3 15
WARFARIN SODIUM 421 421 4 10
OMEPRAZOLE 409 371 5 6
HYDROCODONE-ACETAMINOPHEN 309 251 S3 6 7
LISINOPRIL 308 289 7 3
SIMVASTATIN 292 269 8 1
AMLODIPINE BESYLATE 252 243 9 4
METFORMIN HCL 216 189 10 8
DONEPEZIL HCL 215 215 11 22
METOPROLOL TARTRATE 195 167 12 9
FENTANYL 192 175 S2 13 78
CITALOPRAM HBR 191 167 14 27
CARVEDILOL 169 158 15 20
METOPROLOL SUCCINATE 167 166 16 12
RANITIDINE HCL 166 134 17 37
LANTUS 158 136 18 47
CLOPIDOGREL 145 121 19 30
GABAPENTIN 143 126 20 18
SERTRALINE HCL 141 133 21 26
PRAVASTATIN SODIUM 133 112 22 16
LOSARTAN POTASSIUM 133 130 22 17
SULFAMETHOXAZOLE-TRIMETHOPRIM 129 121 24 127
TAMSULOSIN HCL 126 126 25 23
RISPERIDONE 124 101 26 57
LEVETIRACETAM 120 120 27 90
NOVOLOG 120 103 27 103
ISOSORBIDE MONONITRATE ER 118 118 29 49
NAMENDA 117 117 30 32
ATORVASTATIN CALCIUM 114 103 31 11
GLIMEPIRIDE 114 112 31 39
TRAMADOL HCL 106 100 33 19
CYMBALTA 106 68 33 70
LANTUS SOLOSTAR 105 96 35 93
ZOLPIDEM TARTRATE 103 83 36 24
PREDNISONE 102 87 37 42
ESCITALOPRAM OXALATE 99 97 38 68
DIGOXIN 95 93 39 38
POLYETHYLENE GLYCOL 3350 95 91 39 55
PLAVIX 94 78 41 43
TRIAMTERENE-HCTZ 92 81 42 46
NOVOLOG FLEXPEN 90 88 43 205
ALBUTEROL SULFATE 88 86 44 116
LIDODERM 85 73 45 86
PANTOPRAZOLE SODIUM 85 71 45 28
IPRATROPIUM-ALBUTEROL 84 71 47 104
ADVAIR DISKUS 80 62 48 48
DIOVAN 77 77 49 29
HYDROCHLOROTHIAZIDE 74 65 50 13
MELOXICAM 74 58 50 51
NYSTATIN 73 66 52 196
SPIRONOLACTONE 73 70 52 58
DILTIAZEM 24HR CD 72 72 54 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 68 55 35
AMOX TR-POTASSIUM CLAVULANATE 70 65 56 131
KLOR-CON M20 69 65 57 52
MIRTAZAPINE 68 58 58 63
AZITHROMYCIN 67 63 59 45
CARBIDOPA-LEVODOPA 67 58 59 83
ALLOPURINOL 66 66 61 33
LYRICA 66 51 61 100
RAMIPRIL 66 56 61 111
PRAMIPEXOLE DIHYDROCHLORIDE 65 59 64 188
PAROXETINE HCL 64 62 65 71
JANUVIA 63 63 66 60
ATENOLOL 63 63 66 14
NITROFURANTOIN 63 63 66 372
ALENDRONATE SODIUM 62 55 69 21
LEVOFLOXACIN 61 49 70 77
SPIRIVA 61 57 70 56
HYDRALAZINE HCL 60 56 72 53
ZETIA 59 57 73 69
NIASPAN 58 33 74 115
OXYBUTYNIN CHLORIDE ER 58 48 74 85
METOLAZONE 58 55 74 152
ENOXAPARIN SODIUM 57 57 77 176
PEN NEEDLE 57 49 77 112
SUCRALFATE 55 45 79 193
SINGULAIR 54 43 80 94
LEVEMIR 51 48 81 206
CRESTOR 51 43 81 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.